Literature DB >> 1678957

Asthma specific quality of life scale in a study of salmeterol hydroxynaphthoate.

M E Hyland, G Coward, F Upchurch, K P Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678957      PMCID: PMC1371662     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  4 in total

1.  The mood-peak flow relationship in adult asthmatics: a pilot study of individual differences and direction of causality.

Authors:  M E Hyland
Journal:  Br J Med Psychol       Date:  1990-12

2.  A scale for assessing quality of life in adult asthma sufferers.

Authors:  M E Hyland; S Finnis; S H Irvine
Journal:  J Psychosom Res       Date:  1991       Impact factor: 3.006

3.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

4.  Patients' perception of distress due to symptoms and effects of asthma on daily living and an investigation of possible influential factors.

Authors:  F H Quirk; P W Jones
Journal:  Clin Sci (Lond)       Date:  1990-07       Impact factor: 6.124

  4 in total
  3 in total

1.  The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.

Authors:  M J Sculpher; M J Buxton
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

Review 2.  Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.

Authors:  R N Brogden; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales.

Authors:  Michael E Hyland; Ben Whalley; Rupert C Jones; Matthew Masoli
Journal:  Qual Life Res       Date:  2014-09-09       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.